Collagen Supplements for Skin Aging: The Positive Results Disappear When You Remove Industry Funding Bias

Across all 23 RCTs (n=1,474), collagen supplements appeared to significantly improve skin hydration, elasticity, and wrinkles. However, subgroup analysis by funding source revealed that only pharmaceutical/supplement company-funded studies showed significant effects — independently funded studies showed no benefit in any category. Similarly, high-quality studies showed no significant effect across all skin measures, while low-quality studies showed improvement only in elasticity. The authors concluded there is no clinical evidence to support collagen supplements for skin aging.

Systematic review and meta-analysis of 23 randomized controlled trials (1,474 total participants) identified through PubMed, Embase, and Cochrane Library searches through June 2024. The key innovation was stratifying results by funding source (industry vs. independent) and study quality (high vs. low), which revealed that the overall positive results were driven entirely by industry-funded and lower-quality studies.

The collagen supplement market is worth billions of dollars and growing rapidly, largely based on clinical trials showing skin benefits. This meta-analysis reveals that those positive results are almost entirely driven by industry-funded research and low-quality study designs. It's a striking example of how funding bias and study quality can create a misleading evidence base, and it challenges consumers and clinicians to reconsider the evidence for a very popular supplement.

This study is part of a broader reckoning in supplement science, where meta-analyses that account for funding source and study quality often find that initially promising results evaporate. The collagen supplement industry has grown enormously based on clinical trial data, and this analysis suggests that growth has been built on a biased evidence foundation. Published in The American Journal of Medicine, it carries significant weight in clinical circles.

The meta-analysis is limited by the quality and heterogeneity of the underlying trials. Different collagen types, sources, doses, and durations were pooled together. The subgroup of independently funded studies was likely smaller than the industry-funded group, potentially limiting statistical power to detect real effects. The analysis assessed published outcomes only and could not account for unpublished negative industry trials.